Kodiak Sciences shares soared over 150% at the opening bell after its drugs achieved success in a key trial. The stock continued to rise, doubling in value as the new eye disease drug matched Eylea in a phase 3 trial. Additional reports indicated the stock gained 172% as Kodiak's drugs targeted Regeneron's Eylea. The company's stock price exploded toward $100 following strong phase 3 key trial data for wet AMD.
More Top Stories
ICE sweep in Indiana fuels Jim Banks' campaign
Jim Banks' campaign is capitalizing on a recent ICE sweep in Indiana, which resulted in 426 arrests over five...
EFL Cup roundup: Reading fall to Brentford, VAR draws focus
Reading took a close 1 2 defeat to Brentford in the EFL Cup. After the match, Keith Andrews said VAR is preven...
McDonald's introduces Pokémon Happy Meal on November 5, 2026, collaborating with two beloved franchises
McDonald's is bringing back the Pokémon Happy Meal on November 5, 2026. The meal will include Pokémon themed t...
Texas A&M vs LSU Highlights: Week 4 College Football Showdown Analysis
Week 4 of college football featured several top games including Texas versus Tennessee, Oregon versus USC, and...
Valesca Machado Triumphs at UFC Vegas 121
Valesca Machado achieved victory at the UFC Vegas 121 event. She beat Melissa Amaya to claim the TUF 34 title...
Brown bears take center stage in Fat Bear Week 2026
Fat Bear Week 2026 has begun with 16 brown bears competing for the championship. Chunk, the defending champion...
Weekly Review · Weekly Review · Latest Update · Weekly Review · Latest Update · Weekly Review · News Roundup · Community Report · News Roundup · Local Briefing · Weekly Review · Local Briefing · Latest Update · Daily Digest · Latest Update · Latest Update · Daily Digest · Daily Digest · Local Briefing · News Roundup · Daily Digest · Daily Digest · Daily Digest · News Roundup · Community Report · News Roundup · News Roundup · Latest Update · Weekly Review · Community Report · Local Briefing · Daily Digest · Local Briefing · Local Briefing · Community Report · Latest Update · Weekly Review · Latest Update · Weekly Review · Local Briefing